1-3 of 3
Giuseppina Ruggeri, MD
Close
Sort by
Journal Articles

Molecular Monitoring of NPM1 Is a Useful Tool for Detecting Early-Stage Relapse and to Guide Pre-Emptive Treatment Approaches in Patients with NPM1-Mutated Acute Myeloid Leukemia

Francesca Schieppati, MD, Angela Passi, MD, Erika Borlenghi, MD, Cinzia Lamorgese, Giuseppina Ruggeri, MD, Marco Chiarini, MSc, Viviana Giustini, MSc, Michele Malagola, MD, Chiara Cattaneo, MD, Margherita Sciumé, Giuseppe Rossi, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3931.
https://doi.org/10.1182/blood.V130.Suppl_1.3931.3931
Published: 2017
Journal Articles

An e13a2 Type of BCR-ABL Transcript Has a Significant Adverse Impact on the Achievement of a Sustained Deep Molecular Response and on the Maintenance of a Treatment Free Remission after Stopping Tyrosine Kinase Inhibitors

Mariella D'adda, Mirko Farina, MD, Francesca Schieppati, MD, Elisa Cerqui, MD, Giuseppina Ruggeri, MD, Samantha Ferrari, MD, Chiara Bottelli, MD, Chiara Pagani, MD, Angela Passi, MD, Giuseppe Rossi, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1589.
https://doi.org/10.1182/blood.V130.Suppl_1.1589.1589
Published: 2017
Journal Articles

An Analysis of the Incidence, Risk Factors and Prognosis of Acute Promyelocytic Leukemia Following Mitoxantrone Therapy in Patients Affected by Multiple Sclerosis.

Chiara Cattaneo, MD, Erika Borlenghi, MD, Cinzia Cordioli, MD, Samantha Ferrari, MD, Antonio Regazzoli, MD, Giuseppina Ruggeri, MD, Elena Gobbi, Maria Adele Capucci, MD, Moira Micheletti, MD, Ruggero Capra, MD, Giuseppe Rossi, MD
Journal: Blood
Blood (2006) 108 (11): 4488.
https://doi.org/10.1182/blood.V108.11.4488.4488
Published: 2006